Arizona State University is paying medical marijuana patients to participate in a new medical study. The study is being conducted by ASU researcher Dr. Madeline Meier. Meier oversees work at ASU’s Substance Use, Health, and Behavioral Lab, she is on the forefront of medical marijuana research. Her work has made worldwide headlines.
During her 2012 study Meier found that long-term cannabis use during childhood to adulthood was associated with an eight-point decline in adult IQ. Her research results last year showed that, over long-term use, the worst problem for medical marijuana users was less healthy teeth and gums. There was no signs of lung dysfunction or heart problems, participants in last year’s study had better-than-average body-mass-index, waist circumference, blood-sugar control, and cholesterol readings.
The Scientific Journal Addition published results last month of another study that Meier and ASU researchers conducted that showed no evidence of IQ loss in cannabis users ages 12-18.
Meier declined to comment about the new study at ASU. It’s unclear when the study will end and when the results will the published. According to the project website, the research lab is conducting research on possible links between marijuana use and “psychotic-like experiences, and vascular health,” vaped cannabis, and whether “older marijuana users show neuropsychological impairment and functional impairment in everyday life.”
Information about the new study has been confirmed and posted on the projects website:
“The Substance Use, Health, and Behavior Lab is recruiting participants who are Arizona medical marijuana card holders between the ages of 18 to 30 interested in participating in a study that compares the immediate effects of your at-home use of different types of cannabis.
This study will take approximately 10 hours over the course of 1 week. During this week, participants will be asked to come to the lab for a two hour visit and then receive several text messages per day asking to complete a short survey related to their cannabis use and effects. Participants will be compensated $95 for their voluntary involvement.”
Eligibility requirements and more information about the study can be found by calling the Substance Use, Health and Behavior Lab at 480-727-5799, or emailing [email protected].
